The efficacy of small molecule anti-angiogenic drugs in previously treated Thymic carcinoma
Số trang: 8
Loại file: pdf
Dung lượng: 1.04 MB
Lượt xem: 7
Lượt tải: 0
Xem trước 1 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Antiangiogenic drugs have shown initial efcacy in the treatment of advanced thymic carcinomas (TCs); however, data are limited. In this study, we provide real-world data relating to the efcacy of antiangiogenic drugs for the treatment of patients with TCs.
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Antiangiogenic drugs Thymic carcinomas Anti-angiogenic drugs Overall response rateGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 119 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 37 0 0